Supernus Pharmaceuticals (SUPN) Other financing activities (2011 - 2018)

Supernus Pharmaceuticals (SUPN) has 4 years of Other financing activities data on file, last reported at $65.7 million in Q1 2018.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $65.7 million in Q1 2018; TTM through Dec 2018 was $65.7 million, a N/A change from a year earlier, with the FY2018 full-year figure at $65.7 million, changed N/A from the prior year.
• Other financing activities for Q1 2018 stood at $65.7 million, up from $29000.0 in the prior quarter.
• Over the last five years, Other financing activities for SUPN reached as high as $65.7 million in Q1 2018 and fell as low as $65.7 million in Q1 2018.